Cystemustine
Alternative Names: CMSO2EN2Latest Information Update: 31 Oct 2002
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Nitrosourea compounds; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Colorectal cancer; Glioma; Head and neck cancer; Malignant melanoma; Renal cancer; Sarcoma